#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Noonan syndrome Follicular lymphoma Mitochondrial DNA depletion Complex regional pain syndrome Infertility female Cardiac failure acute Peritoneal mesothelioma malignant Polycystic liver disease Chronic graft versus host disease in intestine Li-Fraumeni syndrome Cardiac amyloidosis Cold type haemolytic anaemia Angiosarcoma recurrent Hypertriglyceridaemia B-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Diagnostics Mastocytosis – Basic Information Activated PI3 kinase delta syndrome Systemic sclerosis pulmonary – Life with Disease Retinitis pigmentosa – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency Mucopolysaccharidosis III – Basic Information Adrenocortical carcinoma – Basic Information Primary mediastinal large B-cell lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Camphor CIRTUVIVINT OSIMERTINIB MESYLATE Zinc Acetate Dihydrate Neob Benralizumab Peposertib Perindopril Arginine Calcium Chloride Lutetium (177Lu) Oxodotreotide Regtivex Propranolol Hydrochloride Other Blood Products Iph6501 Dotatate Clarithromycin Lutropin Alfa Ivabradine Hydrochloride Ganciclovir Sodium Andexanet Alfa More therapies…

    Learn about Your Condition

    Hepatocellular carcinoma Pancreatic carcinoma recurrent Fragile X syndrome Fallopian tube cancer Langerhans cell sarcoma Cervix carcinoma recurrent Systemic scleroderma Cutaneous calcification Cachexia Thrombocytosis Peyronie's disease Perineal injury Procedural hypotension Hepatitis D Nephrolithiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lupus nephritis

  • A Study of Prednisolone, Mycophenolate Mofetil and Voclosporin Compared to Prednisolone and Mycophenolate Mofetil in Patients with Lupus Nephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Voclosporin
    The Netherlands

  • Study on Obinutuzumab for Adolescents with Active Lupus Nephritis and Safety in Children Aged 5 to 12

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Obinutuzumab
    France Italy Poland Spain

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Belimumab
    • Fludarabine Phosphate
    • Mycophenolic Acid
    Austria Czechia Denmark France Germany Hungary +7

  • Study of Obinutuzumab and Mycophenolate Mofetil Without Oral Corticosteroids for Treatment of Lupus Nephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Azathioprine
    • Mycophenolate Mofetil
    France

  • Study on the Safety and Effectiveness of MSV-allo for Patients with Lupus Nephritis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Msv-Allo
    Spain

  • Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Iptacopan Hydrochloride
    • Mycophenolate Sodium
    • Iptacopan
    France Germany Hungary Portugal Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!